Search for: "K"
Results 321 - 340
of 51,908
Sort by Relevance
|
Sort by Date
30 Apr 2024, 3:12 pm
In addition to misclassification, other problem areas in construction that the WHD has identified include: not paying for all hours actually worked (including work done before or after the shift, as well as compensable downtime or meal breaks,) “banking” (a/k/a converting overtime hours into “comp time,” and failing to pay for travel from the shop to the work-site and back. [read post]
30 Apr 2024, 12:44 pm
As a new partner in the Baltimore Library Project, Learning Undefeated will serve 10 K-8 schools this year, including the Maryland School for the Blind. [read post]
30 Apr 2024, 6:31 am
Posted by Benjamin Means (University of South Carolina) and Douglas K. [read post]
30 Apr 2024, 6:31 am
Posted by Benjamin Means (University of South Carolina) and Douglas K. [read post]
30 Apr 2024, 4:58 am
Attorney James K. [read post]
30 Apr 2024, 3:10 am
An HSA Future Value Calculator can help employees project the future value of their account, while an HSA and 401(k) Maximizer can help employees determine how the accounts can collectively support their savings goals. [read post]
29 Apr 2024, 10:00 pm
This guidance provides specific recommendations for all three classes of products—biologics approved under 351(a) of the Public Health Service Act (PHS Act), and biosimilar products and interchangeable biosimilar products approved under 351(k) of the PHS Act—with respect to meeting FDA’s general accuracy and truthful and non-misleading standards that are applied to advertising and promotion of prescription drug products generally. [read post]
29 Apr 2024, 10:00 pm
This guidance provides specific recommendations for all three classes of products—biologics approved under 351(a) of the Public Health Service Act (PHS Act), and biosimilar products and interchangeable biosimilar products approved under 351(k) of the PHS Act—with respect to meeting FDA’s general accuracy and truthful and non-misleading standards that are applied to advertising and promotion of prescription drug products generally. [read post]
29 Apr 2024, 10:00 pm
This guidance provides specific recommendations for all three classes of products—biologics approved under 351(a) of the Public Health Service Act (PHS Act), and biosimilar products and interchangeable biosimilar products approved under 351(k) of the PHS Act—with respect to meeting FDA’s general accuracy and truthful and non-misleading standards that are applied to advertising and promotion of prescription drug products generally. [read post]
29 Apr 2024, 10:00 pm
This guidance provides specific recommendations for all three classes of products—biologics approved under 351(a) of the Public Health Service Act (PHS Act), and biosimilar products and interchangeable biosimilar products approved under 351(k) of the PHS Act—with respect to meeting FDA’s general accuracy and truthful and non-misleading standards that are applied to advertising and promotion of prescription drug products generally. [read post]
29 Apr 2024, 10:00 pm
New and Updated Practical Guidance Content 401(k) and Other Defined Contribution Plan Compliance Resource Kit Form 5500 Annual Reports Executive and Director Perquisites Benchmarking 401(k) Plans Video Cybersecurity Best Practices in Retirement Plans Checklist Retention Bonus and Change in Control Agreement PRACTICAL GUIDANCE CUSTOMER EMAIL EDITION ON THE WEB Experience results today with practical guidance, legal research, and data-driven insights—all in one place. [read post]
29 Apr 2024, 10:00 pm
This guidance provides specific recommendations for all three classes of products—biologics approved under 351(a) of the Public Health Service Act (PHS Act), and biosimilar products and interchangeable biosimilar products approved under 351(k) of the PHS Act—with respect to meeting FDA’s general accuracy and truthful and non-misleading standards that are applied to advertising and promotion of prescription drug products generally. [read post]
29 Apr 2024, 10:00 pm
This guidance provides specific recommendations for all three classes of products—biologics approved under 351(a) of the Public Health Service Act (PHS Act), and biosimilar products and interchangeable biosimilar products approved under 351(k) of the PHS Act—with respect to meeting FDA’s general accuracy and truthful and non-misleading standards that are applied to advertising and promotion of prescription drug products generally. [read post]
29 Apr 2024, 9:01 pm
During the Trump administration, various K-12 schools around the country suspended or otherwise punished students for wearing MAGA attire in particular to class in circumstances that suggest at least the possibility of viewpoint discrimination. [read post]
29 Apr 2024, 8:14 pm
By Larry K. [read post]
29 Apr 2024, 7:35 pm
What Is Norovirus? [read post]
29 Apr 2024, 6:08 pm
Officers Ismael Navarro, K-9 Officer Ahthony Pantoja responded to the scene to question the men. [read post]
29 Apr 2024, 5:04 pm
Susan K. [read post]
29 Apr 2024, 7:05 am
SV 1/2021 (SV 1/2021–23) ECLI:AT:VFGH:2022: SV1.2021 and Verfassungsgerichtshof (Constitutional Court of Austria) Contemporary Practice of the United States Relating to International Law The United States Urges the Seizure of Russian Frozen Assets The United States Provides and Then Rescinds Sanctions Relief for Venezuela The United States Condemns Enactment of Ugandan Anti-homosexuality Act and Imposes Measures in Response Congress Extends Anti-bribery Laws to the Demand Side with… [read post]
29 Apr 2024, 6:35 am
EU Accession and Chinese Investment in CEE Countries Yuleng Zeng Page 486-501 The Chinese Public’s Perceptions of the European Union: Changes and Stability Revealed by 2010 and 2020 Surveys Lisheng Dong, Su Yun Woo, and Daniel Kübler Page 502-520 Research Articles In the Pursuit of the Constructed Truth: Courtroom Questioning as a Persuasive Genre of Talk Kege Li Page 521-543 Rising Income and Wealth Inequality in China: Empirical… [read post]
